Celularity Inc-A

Penny Stocks Biotech Stocks Healthcare Stocks

$1.30

+0.13 (+11.11%)

As of Feb 8, 2:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +855.4% upside

Low Target $7.12

Average Target $12.42

High Target $14.14

Current Price $1.30

Current
$1.30

Target
$12.42

$7.12 $12.42 avg $14.14

Scenario Analysis

Bear Case

$7.12

447.7%

Low target

Base Case

$12.42

+855.4%

Avg target

Bull Case

$14.14

+987.7%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$13.48

-90.4% from high

52-Week Low

$8.55

+-84.8% from low

Target vs 52W High

$12.42

-7.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%